Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

TPA and ATRA a potential one-two punch for cancer of the pancreas

16.08.2005


Croton plant compound combats a second cancer: pancreatic

Rutgers researchers halted prostate cancer in laboratory animals using a compound derived from a Southeast Asian shrub whose leaves produce a poison ivy-like skin rash (ur.rutgers.edu/medrel/viewArticle.html?ArticleID=3837). Now they have achieved the same kind of success with pancreatic cancer.

The cancer-fighting compound, 12-O-tetradecanoylphorbol-13-acetate and generally known as TPA, is found in an oil drawn from seeds of the skin-irritating shrub, the croton plant (Croton tiglium L.). Croton oil has long been known to oriental herbalists for its purgative qualities.



A report of the new discovery by Allan H. Conney at Rutgers, The State University of New Jersey; his student, Gina Avila; and their colleagues is scheduled to appear in the October 2005 issue of The Journal of Pharmacology and Experimental Therapeutics. The report is currently available online at jpet.aspetjournals.org/cgi/reprint/jpet.105.087585v1.

The American Cancer Society predicts that 32,000 Americans will die of pancreatic cancer in 2005, making it the fourth leading cause of cancer death overall. The pancreas is a multipurpose gland in the abdomen that produces enzymes to aid digestion and hormones, such as insulin, that help balance sugar in the blood.

"Pancreas cancer is a tough one to treat. Treatment options are very limited, and not many people survive. TPA has good potential for therapy so it’s definitely worth pursuing," said Conney, State of New Jersey Professor of Chemical Biology, Garbe Professor of Leukemia and Cancer Research, and director of the Susan Lehman Cullman Laboratory for Cancer Research at Rutgers’ Ernest Mario School of Pharmacy.

Encouraged by their progress in the laboratory with prostate cancer, the researchers initiated studies with the pancreas using three human pancreatic cancer cell lines with different molecular properties. In laboratory cultures, the scientists applied TPA to cells from these lines and found that growth of the pancreatic cancer cells was inhibited by TPA when used in concentrations that are achievable in humans – levels that should not be toxic to people.

They also tested TPA on the cells in combination with all-trans retinoic acid (ATRA), a vitamin A derivative previously shown to be effective in treating leukemia.

"We had previously demonstrated that ATRA is an effective synergist with TPA in treating prostate cancer in the laboratory so it was logical to test the combination against pancreatic cancer as well," Conney said. "We found that the TPA/ATRA combination in cell culture worked better than the individual compounds alone."

The researchers injected cells from the human cancer cell lines into immunodeficient mice – mice specifically bred so that their immune systems would not reject foreign biological material – to grow pancreatic tumors against which the compounds could be tested. Once the tumors were well established, Conney and his team began treating the mice with TPA alone and in combination with ATRA. They observed inhibition of tumor growth and reduction in tumor size.

The researchers saw a substantial increase in apoptosis (programmed cell death) and a substantial decrease in mitosis (cells reproducing) in the tumors. "We were simultaneously stopping the growth of new cancer cells and killing those already existing," Conney said. "This was most dramatic when we used the TPA/ATRA combination on the tumors."

He added that the increased efficacy of the potent combination would permit even lower doses to be used. "It is this TPA/ATRA combination, with its lower doses and its demonstrated synergy, that we would very dearly like to see move to human clinical trials."

Joseph Blumberg | EurekAlert!
Further information:
http://www.rutgers.edu

More articles from Life Sciences:

nachricht New technology offers fast peptide synthesis
28.02.2017 | Massachusetts Institute of Technology

nachricht Biofuel produced by microalgae
28.02.2017 | Tokyo Institute of Technology

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Safe glide at total engine failure with ELA-inside

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded after a glide flight with an Airbus A320 in ditching on the Hudson River. All 155 people on board were saved.

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded...

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

New technology offers fast peptide synthesis

28.02.2017 | Life Sciences

WSU research advances energy savings for oil, gas industries

28.02.2017 | Power and Electrical Engineering

Who can find the fish that makes the best sound?

28.02.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>